Deregulation of AR expression is a driver of chromatin relaxation and AR/androgen-regulated bromodomain-containing proteins (BRDs), which are histone acetylation readers, mediate this effect, which helps to stratify patients with tumors in which BRD-mediated TF binding is enhanced or modified as cancer progresses. This evidence concerns the gene AR and cancer.